IFG
VERA icon

Independent Financial Group’s Vera Therapeutics VERA Stock Holding History

Independent Financial Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-87,480
Closed -$1.35M – 1062
2023
Q4 		$1.35M Buy
+87,480
New +$1.11M 0.07% 281

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Independent Financial Group's VERA Position: Q1 2024 in Review

Independent Financial Group sold out of Vera Therapeutics (VERA) in Q1 2024, closing a stake of 87,480 shares — an estimated $1.35M sold.

Independent Financial Group first reported a position in VERA in Q4 2023 and held it in 1 quarter. The position peaked at $1.35M in Q4 2023. 160 funds tracked by Wall St. Rank hold VERA as of Q1 2024.

  • Independent Financial Group reported no remaining Vera Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Independent Financial Group sold 87,480 Vera Therapeutics shares in Q1 2024, an estimated $1.35M.
  • Independent Financial Group first reported a position in Vera Therapeutics in Q4 2023 and held it in 1 quarter.
  • Independent Financial Group's Vera Therapeutics position peaked at $1.35M in Q4 2023.
  • 160 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2024.

Based on Independent Financial Group's 13F filing for Q1 2024, filed 12 Jun 2026.